Pathalys Pharma is a clinical biopharmaceutical company that provides therapeutics development solutions. It offers treatment for patients with end-stage chronic kidney disease (CKD). The company develops Upacicalcet which is a novel calcimimetic that can be delivered intravenously at the end of the hemodialysis session via a pre-filled syringe.